Vimian Group AB (publ) (OTCMKTS:VIMGF) Sees Large Decline in Short Interest

Vimian Group AB (publ) (OTCMKTS:VIMGF) was the target of a large drop in short interest in the month of October. As of October 31st, there was short interest totalling 130,800 shares, a drop of 23.3% from the October 15th total of 170,500 shares. Based on an average daily trading volume, of 400 shares, the days-to-cover ratio is presently 327.0 days.

Vimian Group AB (publ) Price Performance

Shares of VIMGF opened at C$3.56 on Friday. Vimian Group AB has a twelve month low of C$2.68 and a twelve month high of C$4.12. The firm’s 50 day moving average price is C$3.94 and its two-hundred day moving average price is C$3.21.

About Vimian Group AB (publ)

Vimian Group AB (publ) engages in the animal health business worldwide. It operates through Specialty Pharma, MedTech, Diagnostics, and Veterinary Services segments. The company offers proprietary diagnostics, prescription, and non-prescription treatments for preventive care and treatment of chronic conditions for companion animals under the Nextmune brand name; and molecular and immunodiagnostic solutions that are used by laboratories for veterinary specific applications with a focus on livestock and companion animal health markets under the Indical Bioscience brand name.